005257.KS
Green Cross Holdings Corporation
KSC · Healthcare · Biotechnology · KR
KRW 18,000.00
+1.81%Year over year
Reported trailing growth
- Revenue
- +9.7%
- EBITDA
- +21.0%
- EBIT
- -27.5%
- EPS
- —
- Free cash flow
- +183.1%
- Operating cash flow
- +485.3%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +5.2%
- EBITDA
- -6.0%
- EBIT
- -5.9%
- Net income
- +82.2%
- EPS
- +82.2%
- Free cash flow
- +3.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026